1
|
Cheng HLM. A primer on in vivo cell tracking using MRI. Front Med (Lausanne) 2023; 10:1193459. [PMID: 37324153 PMCID: PMC10264782 DOI: 10.3389/fmed.2023.1193459] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2023] [Accepted: 05/12/2023] [Indexed: 06/17/2023] Open
Abstract
Cell tracking by in vivo magnetic resonance imaging (MRI) offers a collection of multiple advantages over other imaging modalities, including high spatial resolution, unlimited depth penetration, 3D visualization, lack of ionizing radiation, and the potential for long-term cell monitoring. Three decades of innovation in both contrast agent chemistry and imaging physics have built an expansive array of probes and methods to track cells non-invasively across a diverse range of applications. In this review, we describe both established and emerging MRI cell tracking approaches and the variety of mechanisms available for contrast generation. Emphasis is given to the advantages, practical limitations, and persistent challenges of each approach, incorporating quantitative comparisons where possible. Toward the end of this review, we take a deeper dive into three key application areas - tracking cancer metastasis, immunotherapy for cancer, and stem cell regeneration - and discuss the cell tracking techniques most suitable to each.
Collapse
Affiliation(s)
- Hai-Ling Margaret Cheng
- Institute of Biomedical Engineering, University of Toronto, Toronto, ON, Canada
- The Edward S. Rogers Sr. Department of Electrical and Computer Engineering, University of Toronto, Toronto, ON, Canada
- Ted Rogers Centre for Heart Research, Translational Biology & Engineering Program, Toronto, ON, Canada
| |
Collapse
|
2
|
Yang BW, Yang S, Kim S, Baek AR, Sung B, Kim YH, Lee JT, Lee SY, Kim HK, Choi G, Park JA, Nam SW, Lee GH, Chang Y. Flavonoid-Conjugated Gadolinium Complexes as Anti-Inflammatory Theranostic Agents. Antioxidants (Basel) 2022; 11:antiox11122470. [PMID: 36552678 PMCID: PMC9774776 DOI: 10.3390/antiox11122470] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2022] [Revised: 12/08/2022] [Accepted: 12/11/2022] [Indexed: 12/23/2022] Open
Abstract
In this study, we designed, synthesized, and evaluated gadolinium compounds conjugated with flavonoids as potential theranostic agents for the treatment of inflammation. These novel theranostic agents combine a molecular imaging agent and one of three flavonoids (galangin, chrysin, and 7-hydroxyflavone) as anti-inflammatory drugs as a single integrated platform. Using these agents, MR imaging showed contrast enhancement (>10 in CNR) at inflamed sites in an animal inflammation model, and subsequent MR imaging used to monitor the therapeutic efficacy of these integrated agents revealed changes in inflamed regions. The anti-inflammatory effects of these agents were demonstrated both in vitro and in vivo. Furthermore, the antioxidant efficacy of the agents was evaluated by measuring their reactive oxygen species scavenging properties. For example, Gd-galangin at 30 μM showed a three-fold higher ROS scavenging of DPPH. Taken together, our findings provide convincing evidence to indicate that flavonoid-conjugated gadolinium compounds can be used as potentially efficient theranostic agents for the treatment of inflammation.
Collapse
Affiliation(s)
- Byeong Woo Yang
- Department of Medical & Biological Engineering, Kyungpook National University, 80 Daehak-ro, Buk-gu, Daegu 41566, Republic of Korea
| | - Sohyeon Yang
- Department of Medical Science, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Republic of Korea
| | - Soyeon Kim
- Division of Applied RI, Korea Institute of Radiological & Medical Sciences (KIRAMS), 75 Nowon-ro, Nowon-gu, Seoul 01812, Republic of Korea
| | - Ah Rum Baek
- Institute of Biomedical Engineering Research, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Republic of Korea
| | - Bokyung Sung
- Department of Medical & Biological Engineering, Kyungpook National University, 80 Daehak-ro, Buk-gu, Daegu 41566, Republic of Korea
| | - Yeoun-Hee Kim
- R&D Center, Etnova Therapeutics Corp., 124, Sagimakgol-ro, Jungwon-gu, Seongnam-si 13207, Republic of Korea
| | - Jung Tae Lee
- Institute of Biomedical Engineering Research, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Republic of Korea
| | - Sang Yun Lee
- Department of Medical & Biological Engineering, Kyungpook National University, 80 Daehak-ro, Buk-gu, Daegu 41566, Republic of Korea
| | - Hee-Kyung Kim
- Preclinical Research Center, Daegu-Gyeongbuk Medical Innovation Foundation, 88 Dongnae-ro, Dong-gu, Daegu 41061, Republic of Korea
| | - Garam Choi
- R&D Center, Etnova Therapeutics Corp., 124, Sagimakgol-ro, Jungwon-gu, Seongnam-si 13207, Republic of Korea
| | - Ji-Ae Park
- Division of Applied RI, Korea Institute of Radiological & Medical Sciences (KIRAMS), 75 Nowon-ro, Nowon-gu, Seoul 01812, Republic of Korea
| | - Sung-Wook Nam
- Department of Molecular Medicine, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Republic of Korea
| | - Gang-Ho Lee
- Department of Chemistry, Kyungpook National University, 80, Daehak-ro, Buk-gu, Daegu 41566, Republic of Korea
| | - Yongmin Chang
- Department of Medical & Biological Engineering, Kyungpook National University, 80 Daehak-ro, Buk-gu, Daegu 41566, Republic of Korea
- Department of Medical Science, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Republic of Korea
- Institute of Biomedical Engineering Research, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Republic of Korea
- Department of Molecular Medicine, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Republic of Korea
- Department of Radiology, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu 41944, Republic of Korea
- Correspondence: ; Tel.: +82-53-420-5471
| |
Collapse
|
3
|
Gawne PJ, Pinto SMA, Nielsen KM, Keeling GP, Pereira MM, T M de Rosales R. Microwave-assisted synthesis of [ 52Mn]Mn-porphyrins: Applications in cell and liposome radiolabelling. Nucl Med Biol 2022; 114-115:6-17. [PMID: 36088876 PMCID: PMC10236072 DOI: 10.1016/j.nucmedbio.2022.08.006] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2022] [Revised: 08/18/2022] [Accepted: 08/22/2022] [Indexed: 12/27/2022]
Abstract
BACKGROUND Manganese porphyrins have several therapeutic/imaging applications, including their use as radioprotectants (in clinical trials) and as paramagnetic MRI contrast agents. The affinity of porphyrins for lipid bilayers also makes them candidates for cell/liposome labelling. We hypothesised that metalation with the positron emission tomography (PET) radionuclide 52Mn (t1/2 = 5.6 d) would allow long-term in vivo biodistribution studies of Mn-porphyrins, as well as a method to label and track cells/liposomes, but methods for fast and efficient radiolabelling are lacking. RESULTS Several porphyrins were produced and radiolabelled by addition to neutralised [52Mn]MnCl2 and heating using a microwave (MW) synthesiser, and compared with non-MW heating. MW radiosynthesis allowed >95 % radiochemical yields (RCY) in just 1 h. Conversely, non-MW heating at 70 °C for 1 h resulted in low RCY (0-25 % RCY) and most porphyrins did not reach radiolabelling completion after 24 h. Formation of the 52Mn-complexes were confirmed with radio-HPLC by comparison with their non-radioactive 55Mn counterparts. Following this, several [52Mn]Mn-porphyrins were used to radiolabel liposomes resulting in 75-86 % labelling efficiency (LE). Two lead [52Mn]Mn-porphyrins were taken forward to label MDA-MB-231 cancer cells in vitro, achieving ca. 11 % LE. After 24 h, 32-45 % of the [52Mn]Mn-porphyrins was retained in cells. CONCLUSIONS In contrast to standard methods, MW heating allows the fast synthesis of [52Mn]Mn-porphyrins with >95 % radiochemical yields that avoid purification. [52Mn]Mn-porphyrins also show promising cell/liposome labelling properties. Our reported technique can potentially be exploited for the in vivo imaging of Mn-porphyrin therapeutics, as well as for the accurate in vivo quantification of Mn-porphyrin MRI agents.
Collapse
Affiliation(s)
- Peter J Gawne
- School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, London, UK
| | - Sara M A Pinto
- Department of Chemistry, University of Coimbra, 3004-535 Coimbra, Portugal
| | - Karin M Nielsen
- School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, London, UK
| | - George P Keeling
- School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, London, UK
| | - Mariette M Pereira
- Department of Chemistry, University of Coimbra, 3004-535 Coimbra, Portugal
| | - Rafael T M de Rosales
- School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, London, UK.
| |
Collapse
|
4
|
Nyström NN, Liu H, Martinez FM, Zhang XA, Scholl TJ, Ronald JA. Gadolinium-free Magnetic Resonance Imaging of the Liver via an Oatp1-Targeted Manganese(III) Porphyrin. J Med Chem 2022; 65:9846-9857. [PMID: 35852350 DOI: 10.1021/acs.jmedchem.2c00500] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
Controversy surrounding gadolinium-based contrast agents (GBCAs) has rendered their continued utility highly contentious, but the liver-specific GBCA Gd(III) ethoxybenzyl-diethylene triamine pentaacetic acid (Gd(III)-EOB-DTPA) remains in use because it provides unique diagnostic information that could not be obtained by any other means. To address the need for an alternate liver-specific MRI probe, we synthesized Mn(III) 20-(4-ethoxyphenyl) porphyrin-5,10,15-tricarboxylate (Mn(III)TriCP-PhOEt), which exhibited significantly higher r1 relaxivity than Gd(III)-EOB-DTPA in vitro, while also targeting hepatocyte-specific organic anion-transporting polypeptide 1 (Oatp1) channels as a marker of viability. In mice, Mn(III)TriCP-PhOEt resulted in significant and specific increases in liver signal intensity on T1-weighted images and significant decreases in liver T1 time relative to pre-contrast measurements. Our findings suggest that Mn(III)TriCP-PhOEt operates as a specific and sensitive MR probe for Oatp1-targeted imaging in vivo.
Collapse
Affiliation(s)
- Nivin N Nyström
- Department of Medical Biophysics, University of Western Ontario, London N6A 3K7, Ontario, Canada
- Imaging Research Laboratories, Robarts Research Institute, Western University, London N6A 3K7, Ontario, Canada
| | - Hanlin Liu
- Department of Chemistry, University of Toronto, Toronto M5S 1A4, Ontario, Canada
- Department of Physical and Environmental Sciences, University of Toronto, Toronto M5S 1A4, Ontario, Canada
| | - Francisco M Martinez
- Imaging Research Laboratories, Robarts Research Institute, Western University, London N6A 3K7, Ontario, Canada
| | - Xiao-An Zhang
- Department of Chemistry, University of Toronto, Toronto M5S 1A4, Ontario, Canada
- Department of Physical and Environmental Sciences, University of Toronto, Toronto M5S 1A4, Ontario, Canada
| | - Timothy J Scholl
- Department of Medical Biophysics, University of Western Ontario, London N6A 3K7, Ontario, Canada
- Imaging Research Laboratories, Robarts Research Institute, Western University, London N6A 3K7, Ontario, Canada
- Ontario Institute for Cancer Research, Toronto M5G 0A3, Ontario, Canada
| | - John A Ronald
- Department of Medical Biophysics, University of Western Ontario, London N6A 3K7, Ontario, Canada
- Imaging Research Laboratories, Robarts Research Institute, Western University, London N6A 3K7, Ontario, Canada
- Lawson Health Research Institute, London N6C 2R5, Ontario, Canada
| |
Collapse
|
5
|
Mallik R, Saha M, Mukherjee C. Porous Silica Nanospheres with a Confined Mono(aquated) Mn(II)-Complex: A Potential T1- T2 Dual Contrast Agent for Magnetic Resonance Imaging. ACS APPLIED BIO MATERIALS 2021; 4:8356-8367. [PMID: 35005912 DOI: 10.1021/acsabm.1c00937] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Magnetic resonance imaging has emerged as an indispensable imaging modality for the early-stage diagnosis of many diseases. The imaging in the presence of a contrast agent is always advantageous, as it mitigates the low-sensitivity issue of the measurements and provides excellent contrast in the acquired images even in a short acquisition time. However, the stability and high relaxivity of the contrast agents remained a challenge. Here, molecules of a mononuclear, mono(aquated), thermodynamically stable [log KMnL = 14.80(7) and pMn = 8.97] Mn(II)-complex (1), based on a hexadentate pyridine-picolinate unit-containing ligand (H2PyDPA), were confined within a porous silica nanosphere in a noncovalent fashion to render a stable nanosystem, complex 1@SiO2NP. The entrapped complex 1 (complex 1@SiO2) exhibited r1 = 8.46 mM-1 s-1 and r2 = 33.15 mM-1 s-1 at pH = 7.4, 25 °C, and 1.41 T in N-(2-hydroxyethyl)piperazine-N'-ethanesulfonic acid buffer. The values were about 2.9 times higher compared to the free (unentrapped)-complex 1 molecules. The synthesized complex 1@SiO2NP interacted significantly with albumin protein and consequently boosted both the relaxivity values to r1 = 24.76 mM-1 s-1 and r2 = 63.96 mM-1 s-1 at pH = 7.4, 37 °C, and 1.41 T. The kinetic inertness of the entrapped molecules was established by recognizing no appreciable change in the r1 value upon challenging complex 1@SiO2NP with 30 and 40 times excess of Zn(II) ions at pH 6 and 25 °C. The water molecule coordinated to the Mn(II) ion in complex 1@SiO2 was also impervious to the physiologically relevant anions (bicarbonate, biphosphate, and citrate) and pH of the medium. Thus, it ensured the availability of the inner-coordination site of complex 1 for the coordination of water molecules in the biological media. The concentration-dependent changes in image intensities in T1- and T2-weighted phantom images and uptake of the nanoparticles by the HeLa cell put forward the biocompatible complex 1@SiO2NP as a potential dual-mode MRI contrast agent, an alternative to Gd(III)-containing contrast agents.
Collapse
Affiliation(s)
- Riya Mallik
- Department of Chemistry, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India
| | - Muktashree Saha
- Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India
| | - Chandan Mukherjee
- Department of Chemistry, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India
| |
Collapse
|
6
|
Geraldes CF, Castro MMC, Peters JA. Mn(III) porphyrins as potential MRI contrast agents for diagnosis and MRI-guided therapy. Coord Chem Rev 2021. [DOI: 10.1016/j.ccr.2021.214069] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
7
|
Lu HS, Wang MY, Ying FP, Lv YY. Manganese(III) porphyrin oligomers as high-relaxivity MRI contrast agents. Bioorg Med Chem 2021; 35:116090. [PMID: 33639594 DOI: 10.1016/j.bmc.2021.116090] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2020] [Revised: 02/10/2021] [Accepted: 02/15/2021] [Indexed: 10/22/2022]
Abstract
Manganese(III) porphyrins (MnIIIPs) as MRI contrast agents (CAs) have drawn particular attention due to their high longitudinal relaxivity (r1) and unique biodistribution. In this work, two MnIIIP-based oligomers, MnPD and MnPT, were designed to further improve the relaxivity with ease of synthesis. The two compounds were fully characterized and their nuclear magnetic relaxation dispersion (NMRD) profiles were acquired with a fast field cycling NMR relaxometer. Both of the compounds exhibited extended high molar r1 at high fields, higher than that of Gd-DTPA, the first clinical gadolinium(III)-based MRI CA. The r1 value of per manganese atom increased with the increasing number of MnIIIP building blocks, suggesting rotational correlation time (τR) played dominant role in the r1 dispersion. The toxicity of the two MnIIIPs and the imaging effectiveness were estimated in vitro and in vivo. With good biocompatibility, significant contrast enhancement, and complete excretion in 24 h, MnPD and MnPT are both promising for high field clinical applications. The applied strategy also potentially provided a facile approach for creation of more MnIIIP oligomer as efficient T1 MRI CAs.
Collapse
Affiliation(s)
- Hui-Shan Lu
- School of Medicine, Zhejiang University City College, Zhejiang, Hangzhou 310015, PR China; College of Pharmacy, Zhejiang University, Zhejiang, Hangzhou 310027, PR China
| | - Meng-Yi Wang
- School of Medicine, Zhejiang University City College, Zhejiang, Hangzhou 310015, PR China
| | - Fei-Peng Ying
- School of Medicine, Zhejiang University City College, Zhejiang, Hangzhou 310015, PR China; College of Pharmacy, Zhejiang University, Zhejiang, Hangzhou 310027, PR China
| | - Yuan-Yuan Lv
- School of Medicine, Zhejiang University City College, Zhejiang, Hangzhou 310015, PR China.
| |
Collapse
|
8
|
Papan P, Kantapan J, Sangthong P, Meepowpan P, Dechsupa N. Iron (III)-Quercetin Complex: Synthesis, Physicochemical Characterization, and MRI Cell Tracking toward Potential Applications in Regenerative Medicine. CONTRAST MEDIA & MOLECULAR IMAGING 2020; 2020:8877862. [PMID: 33456403 PMCID: PMC7785384 DOI: 10.1155/2020/8877862] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/15/2020] [Revised: 12/09/2020] [Accepted: 12/16/2020] [Indexed: 12/20/2022]
Abstract
In cell therapy, contrast agents T1 and T2 are both needed for the labeling and tracking of transplanted stem cells over extended periods of time through magnetic resonance imaging (MRI). Importantly, the metal-quercetin complex via coordination chemistry has been studied extensively for biomedical applications, such as anticancer therapies and imaging probes. Herein, we report on the synthesis, characterization, and labeling of the iron (III)-quercetin complex, "IronQ," in circulating proangiogenic cells (CACs) and also explore tracking via the use of a clinical 1.5 Tesla (T) MRI scanner. Moreover, IronQ had a paramagnetic T1 positive contrast agent property with a saturation magnetization of 0.155 emu/g at 1.0 T and longitudinal relaxivity (r1) values of 2.29 and 3.70 mM-1s-1 at 1.5 T for water and human plasma, respectively. Surprisingly, IronQ was able to promote CAC growth in conventional cell culture systems without the addition of specific growth factors. Increasing dosages of IronQ from 0 to 200 μg/mL led to higher CAC uptake, and maximum labeling time was achieved in 10 days. The accumulated IronQ in CACs was measured by two methodologies, an inductively coupled plasma optical emission spectrometry (ICP-EOS) and T1-weighted MRI. In our research, we confirmed that IronQ has excellent dual functions with the use of an imaging probe for MRI. IronQ can also act as a stimulating agent by favoring circulating proangiogenic cell differentiation. Optimistically, IronQ is considered beneficial for alternative labeling and in the tracking of circulation proangiogenic cells and/or other stem cells in applications of cell therapy through noninvasive magnetic resonance imaging in both preclinical and clinical settings.
Collapse
Affiliation(s)
- Phakorn Papan
- Research Unit of Molecular Imaging Probes and Radiobiology, Department of Radiologic Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
- Department of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand
| | - Jiraporn Kantapan
- Research Unit of Molecular Imaging Probes and Radiobiology, Department of Radiologic Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
| | - Padchanee Sangthong
- Department of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand
| | - Puttinan Meepowpan
- Department of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand
| | - Nathupakorn Dechsupa
- Research Unit of Molecular Imaging Probes and Radiobiology, Department of Radiologic Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
| |
Collapse
|
9
|
A Second Generation Mn-Porphyrin Dimer with a Twisted Linker as a Potential Blood Pool Agent for MRI: Tuning the Geometry and Binding with HSA. Pharmaceuticals (Basel) 2020; 13:ph13100282. [PMID: 33003624 PMCID: PMC7599881 DOI: 10.3390/ph13100282] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2020] [Revised: 09/25/2020] [Accepted: 09/27/2020] [Indexed: 11/23/2022] Open
Abstract
Blood-pool agents (BPAs) are MRI contrast agents (CAs) characterized by their long circulation in the vascular system to provide an extended time window for high-resolution MR angiography (MRA). Prolonged vascular retention, however, impedes the excretion of BPAs. Therefore, chemical strategy to regulate the balance between retention and clearance is important to reach optimal pharmacokinetics. We recently developed MnP2, the first Mn(III)-porphyrin (MnP) based BPA. MnP2 shows high T1 relaxivity (r1) and high affinity to human serum albumin (HSA) that leads to up to 48-h vascular retention in rats. However, upon albumin binding, the r1 is decreased. To modulate vascular retention time and plasma r1, a regioisomer of MnP2, m-MnP2, was synthesized. The free m-MnP2 exhibits lower r1 than that of MnP2 at magnetic fields above 2 MHz, which agrees with their relative hydrodynamic sizes. The HSA binding of m-MnP2 was evaluated using UV-Vis spectroscopy and found to have tuned-down affinity in comparison with MnP2. Upon HSA binding, the protein complex of m-MnP2 exhibits an r1 of 11.8 mM−1 s−1 at 3 T, which is higher than that of MnP2 bound to HSA. Taken together, this demonstrated the role of molecular geometry in optimizing the pharmacokinetics of albumin-targeting BPAs.
Collapse
|
10
|
Gao M, Shen B, Zhou J, Kapre R, Louie AY, Shaw JT. Synthesis and Comparative Evaluation of Photoswitchable Magnetic Resonance Imaging Contrast Agents. ACS OMEGA 2020; 5:14759-14766. [PMID: 32596613 PMCID: PMC7315594 DOI: 10.1021/acsomega.0c01534] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 04/09/2020] [Accepted: 05/25/2020] [Indexed: 06/11/2023]
Abstract
A series of spiropyran (SP)-based magnetic resonance imaging (MRI) contrast agents have been synthesized and evaluated for changes in relaxivity resulting from irradiation with visible light. Both electron-donating and electron-withdrawing substituents were appended to the SP ring in order to study the electronic effects on the photochromic and relaxivity properties of these photoswitchable MRI contrast agents. Photoswitches lacking an electron-withdrawing substituent isomerize readily between the merocyanine and SP forms, while the addition of a nitro group prevents this process. Complexes capable of isomerizing were demonstrated to effect a change in the relaxivity of the appended gadolinium complex.
Collapse
Affiliation(s)
- Mingchun Gao
- Department
of Chemistry, University of California,
Davis, One Shields Avenue, Davis, California 95616, United States
| | - Bowen Shen
- Chemistry
Graduate Group, University of California,
Davis, One Shields Avenue, Davis, California 95616, United States
| | - Junhan Zhou
- Chemistry
Graduate Group, University of California,
Davis, One Shields Avenue, Davis, California 95616, United States
| | - Rohan Kapre
- Department
of Biomedical Engineering, University of
California, Davis, One Shields Avenue, Davis, California 95616, United States
| | - Angelique Y. Louie
- Chemistry
Graduate Group, University of California,
Davis, One Shields Avenue, Davis, California 95616, United States
- Department
of Biomedical Engineering, University of
California, Davis, One Shields Avenue, Davis, California 95616, United States
| | - Jared T. Shaw
- Department
of Chemistry, University of California,
Davis, One Shields Avenue, Davis, California 95616, United States
| |
Collapse
|
11
|
Tse WH, Chen L, McCurdy CM, Tarapacki CM, Chronik BA, Zhang J. Development of biocompatible NaGdF
4
: Er
3+
, Yb
3+
upconversion nanoparticles used as contrast agents for bio‐imaging. CAN J CHEM ENG 2019. [DOI: 10.1002/cjce.23510] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Affiliation(s)
- Wai Hei Tse
- Department of Medical BiophysicsUniversity of Western Ontario London ON Canada
| | - Longyi Chen
- Department of Chemical and Biochemical EngineeringUniversity of Western Ontario London ON Canada
| | - Colin M. McCurdy
- Department of Physics and AstronomyUniversity of Western Ontario London ON Canada
| | | | - Blaine A. Chronik
- Department of Medical BiophysicsUniversity of Western Ontario London ON Canada
- Department of Physics and AstronomyUniversity of Western Ontario London ON Canada
| | - Jin Zhang
- Department of Medical BiophysicsUniversity of Western Ontario London ON Canada
- Department of Physics and AstronomyUniversity of Western Ontario London ON Canada
| |
Collapse
|
12
|
An Efficient T 1 Contrast Agent for Labeling and Tracking Human Embryonic Stem Cells on MRI. CONTRAST MEDIA & MOLECULAR IMAGING 2019; 2019:3475786. [PMID: 31316306 PMCID: PMC6604499 DOI: 10.1155/2019/3475786] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/26/2019] [Accepted: 04/30/2019] [Indexed: 02/06/2023]
Abstract
Noninvasive cell tracking in vivo has the potential to advance stem cell-based therapies into the clinic. Magnetic resonance imaging (MRI) provides an excellent image-guidance platform; however, existing MR cell labeling agents are fraught with limited specificity. To address this unmet need, we developed a highly efficient manganese porphyrin contrast agent, MnEtP, using a two-step synthesis. In vitro MRI at 3 Tesla on human embryonic stem cells (hESCs) demonstrated high labeling efficiency at a very low dose of 10 µM MnEtP, resulting in a four-fold lower T1 relaxation time. This extraordinarily low dose is ideal for labeling large cell numbers required for large animals and humans. Cell viability and differentiation capacity were unaffected. Cellular manganese quantification corroborated MRI findings, and the agent localized primarily on the cell membrane. In vivo MRI of transplanted hESCs in a rat demonstrated excellent sensitivity and specificity of MnEtP for noninvasive stem cell tracking.
Collapse
|
13
|
Wahsner J, Gale EM, Rodríguez-Rodríguez A, Caravan P. Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers. Chem Rev 2019; 119:957-1057. [PMID: 30350585 PMCID: PMC6516866 DOI: 10.1021/acs.chemrev.8b00363] [Citation(s) in RCA: 818] [Impact Index Per Article: 163.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Tens of millions of contrast-enhanced magnetic resonance imaging (MRI) exams are performed annually around the world. The contrast agents, which improve diagnostic accuracy, are almost exclusively small, hydrophilic gadolinium(III) based chelates. In recent years concerns have arisen surrounding the long-term safety of these compounds, and this has spurred research into alternatives. There has also been a push to develop new molecularly targeted contrast agents or agents that can sense pathological changes in the local environment. This comprehensive review describes the state of the art of clinically approved contrast agents, their mechanism of action, and factors influencing their safety. From there we describe different mechanisms of generating MR image contrast such as relaxation, chemical exchange saturation transfer, and direct detection and the types of molecules that are effective for these purposes. Next we describe efforts to make safer contrast agents either by increasing relaxivity, increasing resistance to metal ion release, or by moving to gadolinium(III)-free alternatives. Finally we survey approaches to make contrast agents more specific for pathology either by direct biochemical targeting or by the design of responsive or activatable contrast agents.
Collapse
Affiliation(s)
- Jessica Wahsner
- Athinoula A. Martinos Center for Biomedical Imaging and the Institute for Innovation in Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA
| | - Eric M. Gale
- Athinoula A. Martinos Center for Biomedical Imaging and the Institute for Innovation in Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA
| | - Aurora Rodríguez-Rodríguez
- Athinoula A. Martinos Center for Biomedical Imaging and the Institute for Innovation in Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA
| | - Peter Caravan
- Athinoula A. Martinos Center for Biomedical Imaging and the Institute for Innovation in Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA
| |
Collapse
|
14
|
Pinto SMA, Calvete MJF, Ghica ME, Soler S, Gallardo I, Pallier A, Laranjo MB, Cardoso AMS, Castro MMCA, Brett CMA, Pereira MM, Tóth É, Geraldes CFGC. A biocompatible redox MRI probe based on a Mn(ii)/Mn(iii) porphyrin. Dalton Trans 2019; 48:3249-3262. [DOI: 10.1039/c8dt04775h] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
A water-soluble fluorinated MnIII/II porphyrin responds reversibly to ascorbate redox state as a turn-on MRI probe.
Collapse
|
15
|
Xia L, Zhang C, Li M, Wang K, Wang Y, Xu P, Hu Y. Nitroxide-radicals-modified gold nanorods for in vivo CT/MRI-guided photothermal cancer therapy. Int J Nanomedicine 2018; 13:7123-7134. [PMID: 30464463 PMCID: PMC6228083 DOI: 10.2147/ijn.s171804] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023] Open
Abstract
Purpose This article presents a report of the synthesis, characterization, and biomedical application of nitroxide-radicals-modified gold nanorods (Au-TEMPO NRs) for imaging-guided photothermal cancer therapy. Patients and methods Au nanorods were synthesized through seed-mediated growth method, 4-Amino-TEMPO was added and the reaction proceeded under magnetic stirring. Results With a mean length of 39.2 nm and an average aspect ratio of approximately 3.85, Au-TEMPO NRs showed good photothermal ability when they were irradiated by 808-nm laser. Au-TEMPO NRs could be stored in PBS for more than 1 month, showed no cytotoxicity against both tumor and normal cells at a concentration of up to 3 mg/mL, and functioned as a dual-mode contrast agent for CT/magnetic resonance (MR) imaging in vitro and in vivo, due to their high X-ray attenuation of Au and good r1 relaxivity of nitroxide radicals. Further, they had a long retention time (~4 hours) in the main organs, which enabled a long CT/MR imaging time window for diagnosis. Bio-distribution results revealed that these Au-TEMPO NRs passively aggregated in the liver and spleen. After irradiation by 808-nm laser, Au-TEMPO NRs could ablate the solid tumor in 4T1 tumor-bearing mice, which implied they were a potential theranostic agent for dual-mode imaging and photothermal cancer therapy. Conclusion This type of Au-TEMPO NRs with the abilities of CT/MR imaging and photothermal therapy, can play an active role in imaging-guided photothermal cancer therapy.
Collapse
Affiliation(s)
- Luyao Xia
- Department of Hematology, Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu, 210093, People's Republic of China, .,College of Engineering and Applied Science, Nanjing University, Nanjing, Jiangsu, 210093, People's Republic of China,
| | - Chao Zhang
- Department of Hematology, Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu, 210093, People's Republic of China,
| | - Min Li
- Department of Hematology, Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu, 210093, People's Republic of China,
| | - Kaiyu Wang
- Department of Hematology, Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu, 210093, People's Republic of China,
| | - Yushan Wang
- Department of Hematology, Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu, 210093, People's Republic of China,
| | - Peipei Xu
- Department of Hematology, Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu, 210093, People's Republic of China,
| | - Yong Hu
- College of Engineering and Applied Science, Nanjing University, Nanjing, Jiangsu, 210093, People's Republic of China,
| |
Collapse
|
16
|
Tsuji G, Hattori T, Kato M, Hakamata W, Inoue H, Naito M, Kurihara M, Demizu Y, Shoda T. Design and synthesis of cell-permeable fluorescent nitrilotriacetic acid derivatives. Bioorg Med Chem 2018; 26:5494-5498. [PMID: 30293794 DOI: 10.1016/j.bmc.2018.09.028] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2018] [Revised: 09/20/2018] [Accepted: 09/22/2018] [Indexed: 11/26/2022]
Abstract
Fluorescence labeling of the target molecules using a small molecule-based probe is superior than a method using genetically expressed green fluorescence protein (GFP) in terms of convenience in its preparation and functionalization. Fluorophore-nitrilotriacetic acid (NTA) conjugates with several ester protecting groups were synthesized and evaluated for their cell membrane permeability by fluorescence microscopy analysis. One of the derivatives, acetoxymethyl (AM)-protected NTA conjugate is hydrolyzed, resulting in intracellular accumulation, thus providing localized fluorescence intensity in cells. This modification is expected as an effective method for converting a non-cell membrane permeable NTA-BODIPY conjugates to a cell membrane permeable derivatives.
Collapse
Affiliation(s)
- Genichiro Tsuji
- National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa 210-9501, Japan.
| | - Takayuki Hattori
- National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa 210-9501, Japan
| | - Masashi Kato
- National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa 210-9501, Japan; School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan
| | - Wataru Hakamata
- Department of Chemistry and Life Science, College of Bioresource Sciences, Nihon University, 1866 Kameino, Fujisawa, Kanagawa 252-0880, Japan
| | - Hideshi Inoue
- School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan
| | - Mikihiko Naito
- National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa 210-9501, Japan
| | - Masaaki Kurihara
- National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa 210-9501, Japan
| | - Yosuke Demizu
- National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa 210-9501, Japan
| | - Takuji Shoda
- National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa 210-9501, Japan.
| |
Collapse
|
17
|
Magnetic resonance imaging contrast enhancement in vitro and in vivo by octanuclear iron-oxo cluster-based agents. J Inorg Biochem 2018; 186:176-186. [PMID: 29957454 PMCID: PMC6943819 DOI: 10.1016/j.jinorgbio.2018.06.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2018] [Revised: 05/24/2018] [Accepted: 06/09/2018] [Indexed: 02/03/2023]
Abstract
A water-soluble octanuclear cluster, [Fe8], was studied with regard to its properties as a potential contrast enhancing agent in magnetic resonance imaging (MRI) in magnetic fields of 1.3, 7.2 and 11.9 T and was shown to have transverse relaxivities r2 = 4.01, 10.09 and 15.83 mM s-1, respectively. A related hydrophobic [Fe8] cluster conjugated with 5 kDa hyaluronic acid (HA) was characterized by 57Fe-Mössbauer and MALDI-TOF mass spectroscopy, and was evaluated in aqueous solutions in vitro with regard to its contrast enhancing properties [r2 = 3.65 mM s-1 (1.3 T), 26.20 mM s-1 (7.2 T) and 52.18 mM s-1 (11.9 T)], its in vitro cellular cytotoxicity towards A-549 cells and COS-7 cells and its in vivo enhancement of T2-weighted images (4.7 T) of a human breast cancer xenografted on a nude mouse. The physiologically compatible [Fe8]-HA conjugate was i.v. injected to the tumor-bearing mouse, resulting in observable, heterogeneous signal change within the tumor, evident 15 min after injection and persisting for approximately 30 min. Both molecular [Fe8] and its HA-conjugate show a strong magnetic field dependence on r2, rendering them promising platforms for the further development of T2 MRI contrast agents in high and ultrahigh magnetic fields.
Collapse
|
18
|
Alhamami M, Cheng W, Lyu Y, Allen C, Zhang XA, Cheng HLM. Manganese-porphyrin-enhanced MRI for the detection of cancer cells: A quantitative in vitro investigation with multiple clinical subtypes of breast cancer. PLoS One 2018; 13:e0196998. [PMID: 29795583 PMCID: PMC5993062 DOI: 10.1371/journal.pone.0196998] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2018] [Accepted: 04/24/2018] [Indexed: 01/26/2023] Open
Abstract
Magnetic resonance imaging (MRI) contrast agents (CAs) are chemical compounds that can enhance image contrast on T1- or T2- weighted MR image. We have previously demonstrated the potential of MnCl2, a manganese-based CA, in cellular imaging of breast cancer using T1-weighted MRI. In this work, we examined the potential of another class of manganese-based CAs, manganese porphyrins (MnPs), for sensitive cellular detection of multiple clinical subtypes of breast cancer using quantitative MRI. Using a clinical 3.0-T MRI scanner, the relaxivities of two MnPs, MnTPPS4 and MnTPPS3NH2, and conventional Gd-DTPA (control) were measured in ultrapure water and their T1 contrast enhancement patterns were characterized in multiple clinical subtypes of breast cancer. The toxicity of the three CAs was evaluated in vitro. Compared to Gd-DTPA, both MnTPPS3NH2 and MnTPPS4 enabled a more sensitive multi-subtype detection of four breast cell lines at doses that posed no cytotoxic effects, with MnTPPS3NH2 producing the greatest positive enhancement. The superior T1 enhancement capabilities of MnPs over Gd-DTPA are statistically significant and are likely due to their greater cellular uptake and relaxivities. The results demonstrate that multiple clinical subtypes of breast cancer can be imaged on a 3.0-T MRI scanner using MnPs as T1 cellular CAs.
Collapse
Affiliation(s)
- Mosa Alhamami
- Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
- Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada
- Translational Medicine, Hospital for Sick Children Research Institute, Toronto, Ontario, Canada
| | - Weiran Cheng
- Department of Chemistry, University of Toronto, Toronto, Ontario, Canada
- Department of Physical and Environmental Sciences, University of Toronto Scarborough, Toronto, Ontario, Canada
| | - Yuanyuan Lyu
- Department of Physical and Environmental Sciences, University of Toronto Scarborough, Toronto, Ontario, Canada
- School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang, P. R. China
| | - Christine Allen
- Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
- Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada
- Spatio-Temporal Targeting and Amplification of Radiation Response (STTARR) Innovation Centre, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
| | - Xiao-an Zhang
- Department of Chemistry, University of Toronto, Toronto, Ontario, Canada
- Department of Physical and Environmental Sciences, University of Toronto Scarborough, Toronto, Ontario, Canada
- Department of Biological Sciences, University of Toronto Scarborough, Toronto, Ontario, Canada
| | - Hai-Ling Margaret Cheng
- Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
- Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada
- Translational Medicine, Hospital for Sick Children Research Institute, Toronto, Ontario, Canada
- The Edward S. Rogers Sr. Department of Electrical and Computer Engineering, University of Toronto, Toronto, Ontario, Canada
- Translational Biology and Engineering Program, Ted Rogers Centre for Heart Research, Toronto, Ontario, Canada
| |
Collapse
|
19
|
Xie D, Kim S, Kohli V, Banerjee A, Yu M, Enriquez JS, Luci JJ, Que EL. Hypoxia-Responsive 19F MRI Probes with Improved Redox Properties and Biocompatibility. Inorg Chem 2017; 56:6429-6437. [PMID: 28537705 DOI: 10.1021/acs.inorgchem.7b00500] [Citation(s) in RCA: 52] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
19F magnetic resonance imaging (MRI), an emerging modality in biomedical imaging, has shown promise for in vitro and in vivo preclinical studies. Here we present a series of fluorinated Cu(II)ATSM derivatives for potential use as 19F magnetic resonance agents for sensing cellular hypoxia. The synthesized complexes feature a hypoxia-targeting Cu2+ coordination core, nine equivalent fluorine atoms connected via a variable-length poly(ethylene glycol) linker. Introduction of the fluorine moiety maintains the planar coordination geometry of the Cu2+ center, while the linker length modulates the Cu2+/+ reduction potential, 19F NMR relaxation properties, and lipophilicity. In particular, the 19F NMR relaxation properties were quantitatively evaluated by the Solomon-Bloembergen model, revealing a regular pattern of relaxation enhancement tuned by the distance between Cu2+ and F atoms. Finally, the potential utility of these complexes for sensing reductive environments was demonstrated using both 19F MR phantom imaging and 19F NMR, including experiments in intact live cells.
Collapse
Affiliation(s)
- Da Xie
- Department of Chemistry, The University of Texas at Austin , 105 E. 24th Street Stop A5300, Austin, Texas 78712, United States
| | - Seyong Kim
- Department of Chemistry, The University of Texas at Austin , 105 E. 24th Street Stop A5300, Austin, Texas 78712, United States
| | - Vikraant Kohli
- Department of Chemistry, The University of Texas at Austin , 105 E. 24th Street Stop A5300, Austin, Texas 78712, United States
| | - Arnab Banerjee
- Department of Chemistry, The University of Texas at Austin , 105 E. 24th Street Stop A5300, Austin, Texas 78712, United States
| | - Meng Yu
- Department of Chemistry, The University of Texas at Austin , 105 E. 24th Street Stop A5300, Austin, Texas 78712, United States
| | - José S Enriquez
- Department of Chemistry, The University of Texas at Austin , 105 E. 24th Street Stop A5300, Austin, Texas 78712, United States
| | - Jeffrey J Luci
- Department of Neuroscience, The University of Texas at Austin , Austin, Texas 78712, United States.,Imaging Research Center, The University of Texas at Austin , Austin, Texas 78712, United States
| | - Emily L Que
- Department of Chemistry, The University of Texas at Austin , 105 E. 24th Street Stop A5300, Austin, Texas 78712, United States
| |
Collapse
|
20
|
Wang L, Xia Q, Hou M, Yan C, Xu Y, Qu J, Liu R. A photostable cationic fluorophore for long-term bioimaging. J Mater Chem B 2017; 5:9183-9188. [PMID: 32264600 DOI: 10.1039/c7tb02668d] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
The use of a bright and photostable cationic fluorophore for long-term bioimaging in vitro and in vivo is reported.
Collapse
Affiliation(s)
- Lei Wang
- School of Chemistry and Chemical Engineering
- South China University of Technology
- Guangzhou 510640
- P. R. China
| | - Qi Xia
- School of Pharmaceutical Sciences
- Guangzhou 510515
- P. R. China
| | - Meirong Hou
- Medical Imaging Center
- Nanfang Hospital
- Southern Medical University
- Guangzhou 510515
- P. R. China
| | - Chenggong Yan
- Medical Imaging Center
- Nanfang Hospital
- Southern Medical University
- Guangzhou 510515
- P. R. China
| | - Yikai Xu
- Medical Imaging Center
- Nanfang Hospital
- Southern Medical University
- Guangzhou 510515
- P. R. China
| | - Jinqing Qu
- School of Chemistry and Chemical Engineering
- South China University of Technology
- Guangzhou 510640
- P. R. China
| | - Ruiyuan Liu
- School of Pharmaceutical Sciences
- Guangzhou 510515
- P. R. China
- School of Biomedical Engineering
- Guangzhou 510515
| |
Collapse
|
21
|
Loai S, Haedicke I, Mirzaei Z, Simmons CA, Zhang XA, Cheng HL. Positive-contrast cellular MRI of embryonic stem cells for tissue regeneration using a highly efficientT1MRI contrast agent. J Magn Reson Imaging 2016; 44:1456-1463. [DOI: 10.1002/jmri.25299] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2016] [Revised: 04/20/2016] [Accepted: 04/21/2016] [Indexed: 01/15/2023] Open
Affiliation(s)
- Sadi Loai
- Institute of Biomaterials and Biomedical Engineering; University of Toronto; Toronto ON Canada
- Translational Biology and Engineering Program; Ted Rogers Centre for Heart Research; Toronto ON Canada
- Department of Chemical Engineering and Bioengineering; McMaster University; Hamilton ON Canada
| | - Inga Haedicke
- Department of Physical and Environmental Sciences; University of Toronto Scarborough; Toronto ON Canada
- Department of Chemistry; University of Toronto; Toronto ON Canada
| | - Zahra Mirzaei
- Institute of Biomaterials and Biomedical Engineering; University of Toronto; Toronto ON Canada
- Translational Biology and Engineering Program; Ted Rogers Centre for Heart Research; Toronto ON Canada
| | - Craig A. Simmons
- Institute of Biomaterials and Biomedical Engineering; University of Toronto; Toronto ON Canada
- Translational Biology and Engineering Program; Ted Rogers Centre for Heart Research; Toronto ON Canada
- Department of Mechanical and Industrial Engineering; University of Toronto; Toronto ON Canada
| | - Xiao-an Zhang
- Department of Physical and Environmental Sciences; University of Toronto Scarborough; Toronto ON Canada
- Department of Chemistry; University of Toronto; Toronto ON Canada
| | - Hai Ling Cheng
- Institute of Biomaterials and Biomedical Engineering; University of Toronto; Toronto ON Canada
- Translational Biology and Engineering Program; Ted Rogers Centre for Heart Research; Toronto ON Canada
- The Edward S. Rogers Sr. Department of Electrical and Computer Engineering; University of Toronto Toronto; ON Canada
| |
Collapse
|